Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset

Neurosci Lett. 2017 Sep 29:658:133-136. doi: 10.1016/j.neulet.2017.08.049. Epub 2017 Aug 24.

Abstract

The role of neuroinflammation in Parkinson's disease (PD) has been demonstrated through several different approaches. It was suggested an inflammation-derived oxidative stress and cytokine-dependent toxicity role in the nigrostriatal pathway degeneration and hasten progression of disease. Tumor necrosis factor alpha (TNFA) gene promoter polymorphisms might alter the expression of this cytokine contributing to the pro- and anti-inflammatory polarization. An increased TNFA expression might lead to inflammatory profile predominance. The aim of study was to determine if TNFA haplotypes are associated with PD age at onset. Five polymorphisms in TNFA gene were investigated in 226 patients with idiopathic PD in relation to age at onset. Haplotype grouping was based on allele expression. Logistic binary regression analysis showed that the genetic background leading to higher TNF-α expression confers a higher risk to develop PD earlier. Gender and ancestry did not differ between groups. High TNFA expression may contribute for faster dopaminergic neuron degeneration. In this context, a higher genetic pro-inflammatory profile confers a higher risk to develop PD earlier.

Keywords: Aging; Cytokine; Inflammation; Neurologic disease.

MeSH terms

  • Age of Onset*
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Middle Aged
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / genetics*
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism
  • Polymorphism, Genetic / genetics
  • Promoter Regions, Genetic / genetics
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Tumor Necrosis Factor-alpha